AnaBios is pleased to announce that Gatehouse Bio Chief Executive Officer Dr. David W. Salzman is the winner of the 2024 Translational Research Grant Award. Dr. Salzman will obtain up to $15,000 in AnaBios’ high-quality...
Read MoreAnaBios Announces Winner of 3rd Annual Translational Research Grant
AnaBios is pleased to announce that Dr. Kristine Griffett, Assistant Professor of Pharmacology at Auburn University, is the winner of our third annual Translational Research Grant Award. Dr. Griffett will obtain up to $15,000 in...
Read MoreAnaBios Acquires Cell Systems, Expands Human Cell Portfolio for Drug Discovery
SAN DIEGO, CA – April 4, 2023 – AnaBios Corporation today announced the acquisition of Cell Systems, a human primary cell and cell culture media company located in Kirkland, Washington. The purchase of Cell Systems will...
Read MoreAnaBios Boosts Discovery of Safer, More Effective Medicines with License from University of Louisville
The agreement will drive the discovery of more effective treatments for cardiovascular disease and development of safer drugs with the pre-clinical implementation of advanced human heart models. SAN DIEGO, CA – February 14, 2023 – AnaBios,...
Read MoreRedesigned AnaBios Website Focuses on Human Tissue, Cells & Functional Assays
SAN DIEGO, CA – January 30, 2023 – AnaBios is pleased to announce the redesign of their website describing their human tissue platform offerings, including off-the-shelf and custom tissue samples from their industry-leading biorepository, as well...
Read More